Madryn Asset Management Stakes Big on Venus Concept, Buying 37‑Million Shares and $2.6 Million in Convertible Notes to Boost Capital and Credibility amid Volatile Market Conditions.

Madryn’s Big Bet on Venus Concept

On March 26, 2026 the investor group led by Madryn Asset Management, LP announced a multi‑tiered purchase of Venus Concept Inc. shares. The transaction bundle consists of 37.5 million shares of common stock at just 4¢ each, 37.2 million shares of common stock acquired via promissory‑note consideration, and a substantial tranche of convertible securities—voting and senior preferred shares and secured subordinated convertible notes—amounting to roughly $2.6 million in principal. These purchases bring Madryn’s post‑transaction holdings to over 37.5 million common shares and a comparable volume of preferred and convertible interests.

Implications for Venus Concept and Its Investors

The infusion of capital and the addition of a sophisticated, institutional buyer are likely to be viewed positively by market participants. First, the deal signals confidence in Venus’s niche medical‑aesthetic platform, which is still far below its 52‑week high of $14.50. With the company’s market cap hovering at just $627,270 and its share price near $0.31, a 10 % uptick in social‑media sentiment and a 10.66 % buzz suggest a modest but meaningful shift in investor perception. Second, the convertible notes provide an implicit liquidity cushion: at a conversion rate of 72.6691 common shares per $1,000 of principal, the notes could ultimately expand the outstanding equity base by almost 190,000 shares, diluting the current float but also potentially stabilizing the share price through a future conversion event. Third, the preferred shares’ perpetual nature and fixed conversion ratio (0.0606 for voting and 0.2424 for senior preferred) offer a structured path for the holders to participate in future upside while preserving voting power.

What Investors Should Watch

• Conversion Timing: The conversion clauses are “at the option of the holder” and “under certain conditions.” If Madryn or its affiliates exercise these rights early—especially if Venus reports strong earnings or a strategic partnership—the dilution could be accelerated, impacting the share price.
• Debt‑to‑Equity Balance: The secured subordinated notes carry accrued interest, which will add to Venus’s financial burden until paid or converted. A sharp rise in the company’s interest expense could strain cash flows.
• Price Volatility: With a weekly drop of 13.28% and a year‑to‑date decline of 86.42%, the stock remains highly volatile. The new institutional backing may smooth out short‑term swings but will not eliminate fundamental risk.

Madryn Asset Management, LP: A Brief Profile

Madryn has a track record of deploying sizable capital into the convertible space. In September 2025 the firm purchased 545,335 shares of Series Y Convertible Preferred Stock in Venus, increasing its stake to roughly 2.03 million shares. That same month, Madryn sold an equivalent block of secured subordinated notes, demonstrating a disciplined approach to balancing debt and equity. The current March 26 transaction is a clear extension of this strategy: it blends a bulk purchase of common stock (to gain voting influence and direct equity exposure) with a suite of convertible securities that provide upside participation while limiting immediate dilution. Such a diversified holding suggests Madryn seeks both short‑term price appreciation and long‑term equity participation, positioning itself as a supportive yet watchful investor in Venus Concept’s growth trajectory.

Bottom Line

Madryn’s recent acquisitions inject liquidity and institutional credibility into Venus Concept, yet the company’s steep decline and high volatility mean that investors should remain cautious. The convertible instruments offer upside potential but also add complexity to the capital structure. For those monitoring the medical‑aesthetic niche, the transaction is a signal that seasoned investors see promise—but whether Venus can translate that into sustainable revenue growth and a rebound in share price remains to be seen.